nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—Olsalazine—ulcerative colitis	0.218	0.627	CrCtD
Diflunisal—Mesalazine—ulcerative colitis	0.13	0.373	CrCtD
Diflunisal—osteoarthritis—Prednisone—ulcerative colitis	0.0723	0.5	CpDpCtD
Diflunisal—osteoarthritis—Methylprednisolone—ulcerative colitis	0.0723	0.5	CpDpCtD
Diflunisal—PTGS1—ulcerative colitis	0.0656	0.481	CbGaD
Diflunisal—Olsalazine—Balsalazide—ulcerative colitis	0.0409	0.206	CrCrCtD
Diflunisal—PTGS2—ulcerative colitis	0.0375	0.275	CbGaD
Diflunisal—ALB—ulcerative colitis	0.0334	0.245	CbGaD
Diflunisal—Mesalazine—Olsalazine—ulcerative colitis	0.0332	0.168	CrCrCtD
Diflunisal—Olsalazine—Mesalazine—ulcerative colitis	0.0321	0.162	CrCrCtD
Diflunisal—Olsalazine—Sulfasalazine—ulcerative colitis	0.031	0.156	CrCrCtD
Diflunisal—Aminosalicylic Acid—Mesalazine—ulcerative colitis	0.0283	0.143	CrCrCtD
Diflunisal—PTGS2—Olsalazine—ulcerative colitis	0.0214	0.15	CbGbCtD
Diflunisal—PTGS2—Balsalazide—ulcerative colitis	0.0191	0.134	CbGbCtD
Diflunisal—PTGS1—Olsalazine—ulcerative colitis	0.0181	0.127	CbGbCtD
Diflunisal—Salicylic acid—Mesalazine—ulcerative colitis	0.0163	0.0823	CrCrCtD
Diflunisal—Salsalate—Olsalazine—ulcerative colitis	0.0162	0.0818	CrCrCtD
Diflunisal—PTGS1—Balsalazide—ulcerative colitis	0.0161	0.113	CbGbCtD
Diflunisal—PTGS2—Mesalazine—ulcerative colitis	0.0152	0.107	CbGbCtD
Diflunisal—PTGS1—Mesalazine—ulcerative colitis	0.0129	0.0901	CbGbCtD
Diflunisal—PTGS2—Sulfasalazine—ulcerative colitis	0.00851	0.0596	CbGbCtD
Diflunisal—PTGS2—Triamcinolone—ulcerative colitis	0.00851	0.0596	CbGbCtD
Diflunisal—PTGS2—Betamethasone—ulcerative colitis	0.0073	0.0512	CbGbCtD
Diflunisal—PTGS1—Sulfasalazine—ulcerative colitis	0.00719	0.0504	CbGbCtD
Diflunisal—ALB—Prednisone—ulcerative colitis	0.00429	0.0301	CbGbCtD
Diflunisal—PTGS2—Dexamethasone—ulcerative colitis	0.00425	0.0298	CbGbCtD
Diflunisal—Niclosamide—STAT3—ulcerative colitis	0.000455	0.267	CrCbGaD
Diflunisal—Olsalazine—IFNG—ulcerative colitis	0.00023	0.135	CrCbGaD
Diflunisal—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000193	0.247	CbGdCrCtD
Diflunisal—Aminosalicylic Acid—MPO—ulcerative colitis	0.000115	0.0673	CrCbGaD
Diflunisal—Olsalazine—PPARG—ulcerative colitis	0.000109	0.0636	CrCbGaD
Diflunisal—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	9.3e-05	0.119	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	9.16e-05	0.118	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	9.16e-05	0.118	CbGdCrCtD
Diflunisal—Mesalazine—MPO—ulcerative colitis	9.02e-05	0.0528	CrCbGaD
Diflunisal—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	8.95e-05	0.115	CbGdCrCtD
Diflunisal—TTR—FOXA2 and FOXA3 transcription factor networks—ALB—ulcerative colitis	8.84e-05	0.0108	CbGpPWpGaD
Diflunisal—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	8.35e-05	0.0102	CbGpPWpGaD
Diflunisal—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	8.18e-05	0.00995	CbGpPWpGaD
Diflunisal—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	8.05e-05	0.0098	CbGpPWpGaD
Diflunisal—Olsalazine—PTGS1—ulcerative colitis	8.01e-05	0.0469	CrCbGaD
Diflunisal—Mesalazine—PPARG—ulcerative colitis	8.01e-05	0.0469	CrCbGaD
Diflunisal—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	7.7e-05	0.00937	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—COL18A1—ulcerative colitis	7.54e-05	0.00918	CbGpPWpGaD
Diflunisal—Aminosalicylic Acid—PTGS1—ulcerative colitis	7.53e-05	0.0441	CrCbGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	7.45e-05	0.00907	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	7.38e-05	0.00898	CbGpPWpGaD
Diflunisal—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	7.15e-05	0.0087	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—LAMB1—ulcerative colitis	7.12e-05	0.00867	CbGpPWpGaD
Diflunisal—Salsalate—PTGS1—ulcerative colitis	6.81e-05	0.0399	CrCbGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	6.63e-05	0.00807	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—ITGAL—ulcerative colitis	6.11e-05	0.00744	CbGpPWpGaD
Diflunisal—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	5.96e-05	0.00726	CbGpPWpGaD
Diflunisal—Mesalazine—PTGS1—ulcerative colitis	5.91e-05	0.0346	CrCbGaD
Diflunisal—TTR—Non-integrin membrane-ECM interactions—TGFB1—ulcerative colitis	5.8e-05	0.00706	CbGpPWpGaD
Diflunisal—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	5.61e-05	0.0721	CbGdCrCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	5.6e-05	0.00682	CbGpPWpGaD
Diflunisal—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	5.52e-05	0.0709	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	5.52e-05	0.0709	CbGdCrCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	5.43e-05	0.00661	CbGpPWpGaD
Diflunisal—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	5.4e-05	0.0693	CbGdCrCtD
Diflunisal—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—ulcerative colitis	5.38e-05	0.00655	CbGpPWpGaD
Diflunisal—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	5.35e-05	0.00651	CbGpPWpGaD
Diflunisal—Constipation—Budesonide—ulcerative colitis	4.99e-05	0.00254	CcSEcCtD
Diflunisal—Chest pain—Mesalazine—ulcerative colitis	4.95e-05	0.00252	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	4.82e-05	0.00586	CbGpPWpGaD
Diflunisal—Feeling abnormal—Budesonide—ulcerative colitis	4.81e-05	0.00245	CcSEcCtD
Diflunisal—Confusional state—Mesalazine—ulcerative colitis	4.78e-05	0.00243	CcSEcCtD
Diflunisal—Gastrointestinal pain—Budesonide—ulcerative colitis	4.77e-05	0.00243	CcSEcCtD
Diflunisal—Sweating—Methylprednisolone—ulcerative colitis	4.76e-05	0.00243	CcSEcCtD
Diflunisal—Oedema—Mesalazine—ulcerative colitis	4.74e-05	0.00241	CcSEcCtD
Diflunisal—Anaphylactic shock—Mesalazine—ulcerative colitis	4.74e-05	0.00241	CcSEcCtD
Diflunisal—Hallucination—Hydrocortisone—ulcerative colitis	4.72e-05	0.0024	CcSEcCtD
Diflunisal—Visual impairment—Prednisolone—ulcerative colitis	4.69e-05	0.00239	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	4.68e-05	0.00569	CbGpPWpGaD
Diflunisal—Shock—Mesalazine—ulcerative colitis	4.67e-05	0.00238	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	4.66e-05	0.00567	CbGpPWpGaD
Diflunisal—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	4.65e-05	0.00566	CbGpPWpGaD
Diflunisal—Thrombocytopenia—Mesalazine—ulcerative colitis	4.64e-05	0.00236	CcSEcCtD
Diflunisal—Urticaria—Budesonide—ulcerative colitis	4.63e-05	0.00236	CcSEcCtD
Diflunisal—ALB—Vitamin B12 Metabolism—MPO—ulcerative colitis	4.63e-05	0.00564	CbGpPWpGaD
Diflunisal—Body temperature increased—Budesonide—ulcerative colitis	4.61e-05	0.00235	CcSEcCtD
Diflunisal—Hyperhidrosis—Mesalazine—ulcerative colitis	4.59e-05	0.00233	CcSEcCtD
Diflunisal—Olsalazine—PTGS2—ulcerative colitis	4.58e-05	0.0268	CrCbGaD
Diflunisal—Anorexia—Mesalazine—ulcerative colitis	4.52e-05	0.0023	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	4.51e-05	0.00549	CbGpPWpGaD
Diflunisal—Hallucination—Methylprednisolone—ulcerative colitis	4.44e-05	0.00226	CcSEcCtD
Diflunisal—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	4.43e-05	0.00539	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	4.35e-05	0.0053	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	4.35e-05	0.0053	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	4.31e-05	0.00525	CbGpPWpGaD
Diflunisal—Aminosalicylic Acid—PTGS2—ulcerative colitis	4.31e-05	0.0252	CrCbGaD
Diflunisal—Visual impairment—Methylprednisolone—ulcerative colitis	4.3e-05	0.00219	CcSEcCtD
Diflunisal—Hypersensitivity—Budesonide—ulcerative colitis	4.3e-05	0.00219	CcSEcCtD
Diflunisal—Feeling abnormal—Azathioprine—ulcerative colitis	4.29e-05	0.00218	CcSEcCtD
Diflunisal—Insomnia—Mesalazine—ulcerative colitis	4.29e-05	0.00218	CcSEcCtD
Diflunisal—Paraesthesia—Mesalazine—ulcerative colitis	4.26e-05	0.00217	CcSEcCtD
Diflunisal—Gastrointestinal pain—Azathioprine—ulcerative colitis	4.26e-05	0.00217	CcSEcCtD
Diflunisal—Dyspnoea—Mesalazine—ulcerative colitis	4.23e-05	0.00215	CcSEcCtD
Diflunisal—Somnolence—Mesalazine—ulcerative colitis	4.22e-05	0.00215	CcSEcCtD
Diflunisal—Salicylic acid—PTGS1—ulcerative colitis	4.19e-05	0.0246	CrCbGaD
Diflunisal—Asthenia—Budesonide—ulcerative colitis	4.19e-05	0.00213	CcSEcCtD
Diflunisal—Dyspepsia—Mesalazine—ulcerative colitis	4.18e-05	0.00213	CcSEcCtD
Diflunisal—Pruritus—Budesonide—ulcerative colitis	4.13e-05	0.0021	CcSEcCtD
Diflunisal—Decreased appetite—Mesalazine—ulcerative colitis	4.12e-05	0.0021	CcSEcCtD
Diflunisal—Body temperature increased—Azathioprine—ulcerative colitis	4.12e-05	0.0021	CcSEcCtD
Diflunisal—Fatigue—Mesalazine—ulcerative colitis	4.09e-05	0.00208	CcSEcCtD
Diflunisal—Constipation—Mesalazine—ulcerative colitis	4.06e-05	0.00207	CcSEcCtD
Diflunisal—Hallucination—Betamethasone—ulcerative colitis	4.04e-05	0.00205	CcSEcCtD
Diflunisal—Hallucination—Dexamethasone—ulcerative colitis	4.04e-05	0.00205	CcSEcCtD
Diflunisal—Diarrhoea—Budesonide—ulcerative colitis	3.99e-05	0.00203	CcSEcCtD
Diflunisal—Vision blurred—Prednisolone—ulcerative colitis	3.99e-05	0.00203	CcSEcCtD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	3.91e-05	0.00476	CbGpPWpGaD
Diflunisal—Visual impairment—Dexamethasone—ulcerative colitis	3.91e-05	0.00199	CcSEcCtD
Diflunisal—Visual impairment—Betamethasone—ulcerative colitis	3.91e-05	0.00199	CcSEcCtD
Diflunisal—Feeling abnormal—Mesalazine—ulcerative colitis	3.91e-05	0.00199	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—CHP1—ulcerative colitis	3.9e-05	0.00474	CbGpPWpGaD
Diflunisal—Salsalate—PTGS2—ulcerative colitis	3.89e-05	0.0228	CrCbGaD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	3.89e-05	0.00473	CbGpPWpGaD
Diflunisal—Gastrointestinal pain—Mesalazine—ulcerative colitis	3.88e-05	0.00197	CcSEcCtD
Diflunisal—Angioedema—Prednisolone—ulcerative colitis	3.87e-05	0.00197	CcSEcCtD
Diflunisal—Dizziness—Budesonide—ulcerative colitis	3.86e-05	0.00196	CcSEcCtD
Diflunisal—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	3.84e-05	0.00467	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	3.84e-05	0.00467	CbGpPWpGaD
Diflunisal—Hypersensitivity—Azathioprine—ulcerative colitis	3.84e-05	0.00195	CcSEcCtD
Diflunisal—Vertigo—Prednisolone—ulcerative colitis	3.8e-05	0.00194	CcSEcCtD
Diflunisal—Syncope—Prednisolone—ulcerative colitis	3.8e-05	0.00193	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	3.78e-05	0.0046	CbGpPWpGaD
Diflunisal—Angioedema—Hydrocortisone—ulcerative colitis	3.78e-05	0.00192	CcSEcCtD
Diflunisal—Urticaria—Mesalazine—ulcerative colitis	3.77e-05	0.00192	CcSEcCtD
Diflunisal—ALB—Folate Metabolism—MPO—ulcerative colitis	3.77e-05	0.00459	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	3.75e-05	0.00457	CbGpPWpGaD
Diflunisal—Body temperature increased—Mesalazine—ulcerative colitis	3.75e-05	0.00191	CcSEcCtD
Diflunisal—Loss of consciousness—Prednisolone—ulcerative colitis	3.72e-05	0.00189	CcSEcCtD
Diflunisal—Vertigo—Hydrocortisone—ulcerative colitis	3.71e-05	0.00189	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—VCAM1—ulcerative colitis	3.71e-05	0.00452	CbGpPWpGaD
Diflunisal—Vomiting—Budesonide—ulcerative colitis	3.71e-05	0.00189	CcSEcCtD
Diflunisal—Syncope—Hydrocortisone—ulcerative colitis	3.71e-05	0.00189	CcSEcCtD
Diflunisal—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	3.7e-05	0.0045	CbGpPWpGaD
Diflunisal—Rash—Budesonide—ulcerative colitis	3.68e-05	0.00187	CcSEcCtD
Diflunisal—Dermatitis—Budesonide—ulcerative colitis	3.67e-05	0.00187	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS1—ulcerative colitis	3.67e-05	0.0215	CrCbGaD
Diflunisal—Headache—Budesonide—ulcerative colitis	3.65e-05	0.00186	CcSEcCtD
Diflunisal—Loss of consciousness—Hydrocortisone—ulcerative colitis	3.63e-05	0.00185	CcSEcCtD
Diflunisal—Diarrhoea—Azathioprine—ulcerative colitis	3.56e-05	0.00181	CcSEcCtD
Diflunisal—Angioedema—Triamcinolone—ulcerative colitis	3.56e-05	0.00181	CcSEcCtD
Diflunisal—Angioedema—Methylprednisolone—ulcerative colitis	3.55e-05	0.00181	CcSEcCtD
Diflunisal—Hallucination—Prednisone—ulcerative colitis	3.52e-05	0.00179	CcSEcCtD
Diflunisal—Vertigo—Triamcinolone—ulcerative colitis	3.5e-05	0.00178	CcSEcCtD
Diflunisal—Hypersensitivity—Mesalazine—ulcerative colitis	3.5e-05	0.00178	CcSEcCtD
Diflunisal—Syncope—Triamcinolone—ulcerative colitis	3.49e-05	0.00178	CcSEcCtD
Diflunisal—Vertigo—Methylprednisolone—ulcerative colitis	3.49e-05	0.00178	CcSEcCtD
Diflunisal—Syncope—Methylprednisolone—ulcerative colitis	3.48e-05	0.00177	CcSEcCtD
Diflunisal—Nausea—Budesonide—ulcerative colitis	3.47e-05	0.00176	CcSEcCtD
Diflunisal—Oedema—Prednisolone—ulcerative colitis	3.45e-05	0.00176	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisolone—ulcerative colitis	3.45e-05	0.00176	CcSEcCtD
Diflunisal—Dizziness—Azathioprine—ulcerative colitis	3.44e-05	0.00175	CcSEcCtD
Diflunisal—Loss of consciousness—Triamcinolone—ulcerative colitis	3.42e-05	0.00174	CcSEcCtD
Diflunisal—Loss of consciousness—Methylprednisolone—ulcerative colitis	3.41e-05	0.00174	CcSEcCtD
Diflunisal—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	3.4e-05	0.00414	CbGpPWpGaD
Diflunisal—Asthenia—Mesalazine—ulcerative colitis	3.4e-05	0.00173	CcSEcCtD
Diflunisal—Shock—Prednisolone—ulcerative colitis	3.4e-05	0.00173	CcSEcCtD
Diflunisal—Mesalazine—PTGS2—ulcerative colitis	3.38e-05	0.0198	CrCbGaD
Diflunisal—Anaphylactic shock—Hydrocortisone—ulcerative colitis	3.37e-05	0.00172	CcSEcCtD
Diflunisal—Oedema—Hydrocortisone—ulcerative colitis	3.37e-05	0.00172	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—DLD—ulcerative colitis	3.37e-05	0.0041	CbGpPWpGaD
Diflunisal—Pruritus—Mesalazine—ulcerative colitis	3.36e-05	0.00171	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisolone—ulcerative colitis	3.34e-05	0.0017	CcSEcCtD
Diflunisal—Shock—Hydrocortisone—ulcerative colitis	3.32e-05	0.00169	CcSEcCtD
Diflunisal—TTR—Disease—CHP1—ulcerative colitis	3.32e-05	0.00404	CbGpPWpGaD
Diflunisal—Vomiting—Azathioprine—ulcerative colitis	3.31e-05	0.00169	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	3.31e-05	0.00403	CbGpPWpGaD
Diflunisal—Rash—Azathioprine—ulcerative colitis	3.28e-05	0.00167	CcSEcCtD
Diflunisal—Dermatitis—Azathioprine—ulcerative colitis	3.28e-05	0.00167	CcSEcCtD
Diflunisal—Flushing—Prednisone—ulcerative colitis	3.28e-05	0.00167	CcSEcCtD
Diflunisal—Headache—Azathioprine—ulcerative colitis	3.26e-05	0.00166	CcSEcCtD
Diflunisal—Hyperhidrosis—Hydrocortisone—ulcerative colitis	3.26e-05	0.00166	CcSEcCtD
Diflunisal—Diarrhoea—Mesalazine—ulcerative colitis	3.25e-05	0.00165	CcSEcCtD
Diflunisal—Angioedema—Dexamethasone—ulcerative colitis	3.23e-05	0.00164	CcSEcCtD
Diflunisal—Angioedema—Betamethasone—ulcerative colitis	3.23e-05	0.00164	CcSEcCtD
Diflunisal—Anorexia—Hydrocortisone—ulcerative colitis	3.22e-05	0.00164	CcSEcCtD
Diflunisal—Confusional state—Methylprednisolone—ulcerative colitis	3.2e-05	0.00163	CcSEcCtD
Diflunisal—Oedema—Triamcinolone—ulcerative colitis	3.18e-05	0.00162	CcSEcCtD
Diflunisal—Anaphylactic shock—Triamcinolone—ulcerative colitis	3.18e-05	0.00162	CcSEcCtD
Diflunisal—Vertigo—Betamethasone—ulcerative colitis	3.17e-05	0.00162	CcSEcCtD
Diflunisal—Vertigo—Dexamethasone—ulcerative colitis	3.17e-05	0.00162	CcSEcCtD
Diflunisal—Anaphylactic shock—Methylprednisolone—ulcerative colitis	3.17e-05	0.00161	CcSEcCtD
Diflunisal—Syncope—Betamethasone—ulcerative colitis	3.17e-05	0.00161	CcSEcCtD
Diflunisal—Syncope—Dexamethasone—ulcerative colitis	3.17e-05	0.00161	CcSEcCtD
Diflunisal—Dizziness—Mesalazine—ulcerative colitis	3.14e-05	0.0016	CcSEcCtD
Diflunisal—Shock—Triamcinolone—ulcerative colitis	3.13e-05	0.00159	CcSEcCtD
Diflunisal—Insomnia—Prednisolone—ulcerative colitis	3.12e-05	0.00159	CcSEcCtD
Diflunisal—Shock—Methylprednisolone—ulcerative colitis	3.12e-05	0.00159	CcSEcCtD
Diflunisal—Loss of consciousness—Dexamethasone—ulcerative colitis	3.1e-05	0.00158	CcSEcCtD
Diflunisal—Loss of consciousness—Betamethasone—ulcerative colitis	3.1e-05	0.00158	CcSEcCtD
Diflunisal—Paraesthesia—Prednisolone—ulcerative colitis	3.1e-05	0.00158	CcSEcCtD
Diflunisal—Nausea—Azathioprine—ulcerative colitis	3.09e-05	0.00157	CcSEcCtD
Diflunisal—Hyperhidrosis—Triamcinolone—ulcerative colitis	3.07e-05	0.00156	CcSEcCtD
Diflunisal—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3.06e-05	0.00156	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	3.05e-05	0.00371	CbGpPWpGaD
Diflunisal—Insomnia—Hydrocortisone—ulcerative colitis	3.05e-05	0.00155	CcSEcCtD
Diflunisal—Paraesthesia—Hydrocortisone—ulcerative colitis	3.03e-05	0.00154	CcSEcCtD
Diflunisal—Vomiting—Mesalazine—ulcerative colitis	3.02e-05	0.00154	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	3e-05	0.00365	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—MPO—ulcerative colitis	2.99e-05	0.00364	CbGpPWpGaD
Diflunisal—Rash—Mesalazine—ulcerative colitis	2.99e-05	0.00152	CcSEcCtD
Diflunisal—Dermatitis—Mesalazine—ulcerative colitis	2.99e-05	0.00152	CcSEcCtD
Diflunisal—Headache—Mesalazine—ulcerative colitis	2.97e-05	0.00151	CcSEcCtD
Diflunisal—Dyspepsia—Hydrocortisone—ulcerative colitis	2.97e-05	0.00151	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	2.96e-05	0.00361	CbGpPWpGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	2.94e-05	0.00358	CbGpPWpGaD
Diflunisal—Decreased appetite—Hydrocortisone—ulcerative colitis	2.93e-05	0.00149	CcSEcCtD
Diflunisal—Fatigue—Hydrocortisone—ulcerative colitis	2.91e-05	0.00148	CcSEcCtD
Diflunisal—Vision blurred—Prednisone—ulcerative colitis	2.9e-05	0.00148	CcSEcCtD
Diflunisal—Oedema—Dexamethasone—ulcerative colitis	2.88e-05	0.00147	CcSEcCtD
Diflunisal—Anaphylactic shock—Betamethasone—ulcerative colitis	2.88e-05	0.00147	CcSEcCtD
Diflunisal—Anaphylactic shock—Dexamethasone—ulcerative colitis	2.88e-05	0.00147	CcSEcCtD
Diflunisal—Oedema—Betamethasone—ulcerative colitis	2.88e-05	0.00147	CcSEcCtD
Diflunisal—Insomnia—Triamcinolone—ulcerative colitis	2.87e-05	0.00146	CcSEcCtD
Diflunisal—Insomnia—Methylprednisolone—ulcerative colitis	2.87e-05	0.00146	CcSEcCtD
Diflunisal—Paraesthesia—Triamcinolone—ulcerative colitis	2.85e-05	0.00145	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisolone—ulcerative colitis	2.85e-05	0.00145	CcSEcCtD
Diflunisal—Paraesthesia—Methylprednisolone—ulcerative colitis	2.85e-05	0.00145	CcSEcCtD
Diflunisal—Shock—Dexamethasone—ulcerative colitis	2.84e-05	0.00144	CcSEcCtD
Diflunisal—Shock—Betamethasone—ulcerative colitis	2.84e-05	0.00144	CcSEcCtD
Diflunisal—Dyspnoea—Triamcinolone—ulcerative colitis	2.83e-05	0.00144	CcSEcCtD
Diflunisal—Thrombocytopenia—Dexamethasone—ulcerative colitis	2.82e-05	0.00144	CcSEcCtD
Diflunisal—Thrombocytopenia—Betamethasone—ulcerative colitis	2.82e-05	0.00144	CcSEcCtD
Diflunisal—Nausea—Mesalazine—ulcerative colitis	2.82e-05	0.00143	CcSEcCtD
Diflunisal—Angioedema—Prednisone—ulcerative colitis	2.81e-05	0.00143	CcSEcCtD
Diflunisal—Dyspepsia—Triamcinolone—ulcerative colitis	2.8e-05	0.00142	CcSEcCtD
Diflunisal—Dyspepsia—Methylprednisolone—ulcerative colitis	2.79e-05	0.00142	CcSEcCtD
Diflunisal—Hyperhidrosis—Betamethasone—ulcerative colitis	2.79e-05	0.00142	CcSEcCtD
Diflunisal—Hyperhidrosis—Dexamethasone—ulcerative colitis	2.79e-05	0.00142	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—MMP1—ulcerative colitis	2.78e-05	0.00338	CbGpPWpGaD
Diflunisal—Feeling abnormal—Hydrocortisone—ulcerative colitis	2.78e-05	0.00142	CcSEcCtD
Diflunisal—Vertigo—Prednisone—ulcerative colitis	2.76e-05	0.00141	CcSEcCtD
Diflunisal—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	2.76e-05	0.0014	CcSEcCtD
Diflunisal—Syncope—Prednisone—ulcerative colitis	2.76e-05	0.0014	CcSEcCtD
Diflunisal—ALB—Selenium Micronutrient Network—PTGS1—ulcerative colitis	2.75e-05	0.00335	CbGpPWpGaD
Diflunisal—Anorexia—Betamethasone—ulcerative colitis	2.75e-05	0.0014	CcSEcCtD
Diflunisal—Anorexia—Dexamethasone—ulcerative colitis	2.75e-05	0.0014	CcSEcCtD
Diflunisal—Urticaria—Prednisolone—ulcerative colitis	2.74e-05	0.0014	CcSEcCtD
Diflunisal—Fatigue—Triamcinolone—ulcerative colitis	2.74e-05	0.00139	CcSEcCtD
Diflunisal—Fatigue—Methylprednisolone—ulcerative colitis	2.73e-05	0.00139	CcSEcCtD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	2.71e-05	0.0033	CbGpPWpGaD
Diflunisal—Loss of consciousness—Prednisone—ulcerative colitis	2.7e-05	0.00138	CcSEcCtD
Diflunisal—Urticaria—Hydrocortisone—ulcerative colitis	2.68e-05	0.00136	CcSEcCtD
Diflunisal—ALB—Platelet degranulation—CALM3—ulcerative colitis	2.68e-05	0.00326	CbGpPWpGaD
Diflunisal—Body temperature increased—Hydrocortisone—ulcerative colitis	2.67e-05	0.00136	CcSEcCtD
Diflunisal—TTR—Disease—SEL1L—ulcerative colitis	2.64e-05	0.00321	CbGpPWpGaD
Diflunisal—Feeling abnormal—Triamcinolone—ulcerative colitis	2.62e-05	0.00133	CcSEcCtD
Diflunisal—Feeling abnormal—Methylprednisolone—ulcerative colitis	2.61e-05	0.00133	CcSEcCtD
Diflunisal—Insomnia—Betamethasone—ulcerative colitis	2.61e-05	0.00133	CcSEcCtD
Diflunisal—Insomnia—Dexamethasone—ulcerative colitis	2.61e-05	0.00133	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	2.61e-05	0.00317	CbGpPWpGaD
Diflunisal—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	2.59e-05	0.00132	CcSEcCtD
Diflunisal—Paraesthesia—Dexamethasone—ulcerative colitis	2.59e-05	0.00132	CcSEcCtD
Diflunisal—Paraesthesia—Betamethasone—ulcerative colitis	2.59e-05	0.00132	CcSEcCtD
Diflunisal—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.58e-05	0.00314	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	2.55e-05	0.0031	CbGpPWpGaD
Diflunisal—Hypersensitivity—Prednisolone—ulcerative colitis	2.54e-05	0.0013	CcSEcCtD
Diflunisal—Dyspepsia—Dexamethasone—ulcerative colitis	2.54e-05	0.00129	CcSEcCtD
Diflunisal—Dyspepsia—Betamethasone—ulcerative colitis	2.54e-05	0.00129	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—ICAM1—ulcerative colitis	2.53e-05	0.00308	CbGpPWpGaD
Diflunisal—Urticaria—Triamcinolone—ulcerative colitis	2.52e-05	0.00128	CcSEcCtD
Diflunisal—Urticaria—Methylprednisolone—ulcerative colitis	2.52e-05	0.00128	CcSEcCtD
Diflunisal—Body temperature increased—Triamcinolone—ulcerative colitis	2.51e-05	0.00128	CcSEcCtD
Diflunisal—Oedema—Prednisone—ulcerative colitis	2.51e-05	0.00128	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisone—ulcerative colitis	2.51e-05	0.00128	CcSEcCtD
Diflunisal—Decreased appetite—Dexamethasone—ulcerative colitis	2.51e-05	0.00128	CcSEcCtD
Diflunisal—Decreased appetite—Betamethasone—ulcerative colitis	2.51e-05	0.00128	CcSEcCtD
Diflunisal—Hypersensitivity—Hydrocortisone—ulcerative colitis	2.49e-05	0.00127	CcSEcCtD
Diflunisal—Fatigue—Dexamethasone—ulcerative colitis	2.48e-05	0.00126	CcSEcCtD
Diflunisal—Fatigue—Betamethasone—ulcerative colitis	2.48e-05	0.00126	CcSEcCtD
Diflunisal—Shock—Prednisone—ulcerative colitis	2.47e-05	0.00126	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	2.45e-05	0.00298	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—CRP—ulcerative colitis	2.44e-05	0.00296	CbGpPWpGaD
Diflunisal—Hyperhidrosis—Prednisone—ulcerative colitis	2.43e-05	0.00124	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	2.42e-05	0.00295	CbGpPWpGaD
Diflunisal—Asthenia—Hydrocortisone—ulcerative colitis	2.42e-05	0.00123	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—ulcerative colitis	2.4e-05	0.014	CrCbGaD
Diflunisal—Anorexia—Prednisone—ulcerative colitis	2.39e-05	0.00122	CcSEcCtD
Diflunisal—Pruritus—Hydrocortisone—ulcerative colitis	2.39e-05	0.00121	CcSEcCtD
Diflunisal—Feeling abnormal—Dexamethasone—ulcerative colitis	2.38e-05	0.00121	CcSEcCtD
Diflunisal—Feeling abnormal—Betamethasone—ulcerative colitis	2.38e-05	0.00121	CcSEcCtD
Diflunisal—TTR—Disease—LTF—ulcerative colitis	2.36e-05	0.00288	CbGpPWpGaD
Diflunisal—Gastrointestinal pain—Betamethasone—ulcerative colitis	2.36e-05	0.0012	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dexamethasone—ulcerative colitis	2.36e-05	0.0012	CcSEcCtD
Diflunisal—Hypersensitivity—Triamcinolone—ulcerative colitis	2.34e-05	0.00119	CcSEcCtD
Diflunisal—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.34e-05	0.00119	CcSEcCtD
Diflunisal—Diarrhoea—Hydrocortisone—ulcerative colitis	2.31e-05	0.00117	CcSEcCtD
Diflunisal—Urticaria—Betamethasone—ulcerative colitis	2.29e-05	0.00117	CcSEcCtD
Diflunisal—Urticaria—Dexamethasone—ulcerative colitis	2.29e-05	0.00117	CcSEcCtD
Diflunisal—Dizziness—Prednisolone—ulcerative colitis	2.28e-05	0.00116	CcSEcCtD
Diflunisal—Asthenia—Triamcinolone—ulcerative colitis	2.28e-05	0.00116	CcSEcCtD
Diflunisal—Body temperature increased—Dexamethasone—ulcerative colitis	2.28e-05	0.00116	CcSEcCtD
Diflunisal—Body temperature increased—Betamethasone—ulcerative colitis	2.28e-05	0.00116	CcSEcCtD
Diflunisal—Asthenia—Methylprednisolone—ulcerative colitis	2.27e-05	0.00116	CcSEcCtD
Diflunisal—Insomnia—Prednisone—ulcerative colitis	2.27e-05	0.00116	CcSEcCtD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	2.26e-05	0.00275	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	2.26e-05	0.00275	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	2.26e-05	0.00275	CbGpPWpGaD
Diflunisal—Paraesthesia—Prednisone—ulcerative colitis	2.25e-05	0.00115	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	2.25e-05	0.00274	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PROCR—ulcerative colitis	2.25e-05	0.00274	CbGpPWpGaD
Diflunisal—Pruritus—Triamcinolone—ulcerative colitis	2.25e-05	0.00114	CcSEcCtD
Diflunisal—Pruritus—Methylprednisolone—ulcerative colitis	2.24e-05	0.00114	CcSEcCtD
Diflunisal—ALB—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	2.24e-05	0.00272	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—CDH1—ulcerative colitis	2.23e-05	0.00272	CbGpPWpGaD
Diflunisal—Dizziness—Hydrocortisone—ulcerative colitis	2.23e-05	0.00114	CcSEcCtD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	2.21e-05	0.00269	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	2.21e-05	0.00269	CbGpPWpGaD
Diflunisal—Dyspepsia—Prednisone—ulcerative colitis	2.21e-05	0.00112	CcSEcCtD
Diflunisal—Decreased appetite—Prednisone—ulcerative colitis	2.18e-05	0.00111	CcSEcCtD
Diflunisal—Rash—Prednisolone—ulcerative colitis	2.18e-05	0.00111	CcSEcCtD
Diflunisal—Dermatitis—Prednisolone—ulcerative colitis	2.18e-05	0.00111	CcSEcCtD
Diflunisal—Diarrhoea—Methylprednisolone—ulcerative colitis	2.17e-05	0.0011	CcSEcCtD
Diflunisal—Fatigue—Prednisone—ulcerative colitis	2.16e-05	0.0011	CcSEcCtD
Diflunisal—Headache—Prednisolone—ulcerative colitis	2.16e-05	0.0011	CcSEcCtD
Diflunisal—Constipation—Prednisone—ulcerative colitis	2.15e-05	0.00109	CcSEcCtD
Diflunisal—Vomiting—Hydrocortisone—ulcerative colitis	2.14e-05	0.00109	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	2.14e-05	0.0026	CbGpPWpGaD
Diflunisal—Salicylic acid—ALB—ulcerative colitis	2.13e-05	0.0125	CrCbGaD
Diflunisal—Rash—Hydrocortisone—ulcerative colitis	2.13e-05	0.00108	CcSEcCtD
Diflunisal—Dermatitis—Hydrocortisone—ulcerative colitis	2.13e-05	0.00108	CcSEcCtD
Diflunisal—Headache—Hydrocortisone—ulcerative colitis	2.11e-05	0.00108	CcSEcCtD
Diflunisal—Dizziness—Triamcinolone—ulcerative colitis	2.1e-05	0.00107	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—ulcerative colitis	2.1e-05	0.0123	CrCbGaD
Diflunisal—Dizziness—Methylprednisolone—ulcerative colitis	2.1e-05	0.00107	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisone—ulcerative colitis	2.07e-05	0.00105	CcSEcCtD
Diflunisal—Asthenia—Dexamethasone—ulcerative colitis	2.07e-05	0.00105	CcSEcCtD
Diflunisal—Asthenia—Betamethasone—ulcerative colitis	2.07e-05	0.00105	CcSEcCtD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	2.05e-05	0.0025	CbGpPWpGaD
Diflunisal—Gastrointestinal pain—Prednisone—ulcerative colitis	2.05e-05	0.00104	CcSEcCtD
Diflunisal—Nausea—Prednisolone—ulcerative colitis	2.05e-05	0.00104	CcSEcCtD
Diflunisal—Pruritus—Betamethasone—ulcerative colitis	2.04e-05	0.00104	CcSEcCtD
Diflunisal—Pruritus—Dexamethasone—ulcerative colitis	2.04e-05	0.00104	CcSEcCtD
Diflunisal—Salicylic acid—ABCB1—ulcerative colitis	2.04e-05	0.0119	CrCbGaD
Diflunisal—Vomiting—Triamcinolone—ulcerative colitis	2.02e-05	0.00103	CcSEcCtD
Diflunisal—Vomiting—Methylprednisolone—ulcerative colitis	2.02e-05	0.00103	CcSEcCtD
Diflunisal—Nausea—Hydrocortisone—ulcerative colitis	2e-05	0.00102	CcSEcCtD
Diflunisal—Rash—Triamcinolone—ulcerative colitis	2e-05	0.00102	CcSEcCtD
Diflunisal—Dermatitis—Triamcinolone—ulcerative colitis	2e-05	0.00102	CcSEcCtD
Diflunisal—Rash—Methylprednisolone—ulcerative colitis	2e-05	0.00102	CcSEcCtD
Diflunisal—Dermatitis—Methylprednisolone—ulcerative colitis	2e-05	0.00102	CcSEcCtD
Diflunisal—Urticaria—Prednisone—ulcerative colitis	1.99e-05	0.00102	CcSEcCtD
Diflunisal—Headache—Triamcinolone—ulcerative colitis	1.99e-05	0.00101	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	1.99e-05	0.00242	CbGpPWpGaD
Diflunisal—Headache—Methylprednisolone—ulcerative colitis	1.99e-05	0.00101	CcSEcCtD
Diflunisal—Body temperature increased—Prednisone—ulcerative colitis	1.98e-05	0.00101	CcSEcCtD
Diflunisal—ALB—Folate Metabolism—CRP—ulcerative colitis	1.98e-05	0.00241	CbGpPWpGaD
Diflunisal—Diarrhoea—Dexamethasone—ulcerative colitis	1.97e-05	0.001	CcSEcCtD
Diflunisal—Diarrhoea—Betamethasone—ulcerative colitis	1.97e-05	0.001	CcSEcCtD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	1.95e-05	0.00237	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	1.95e-05	0.00237	CbGpPWpGaD
Diflunisal—Dizziness—Dexamethasone—ulcerative colitis	1.91e-05	0.00097	CcSEcCtD
Diflunisal—Dizziness—Betamethasone—ulcerative colitis	1.91e-05	0.00097	CcSEcCtD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	1.9e-05	0.00232	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	1.9e-05	0.00231	CbGpPWpGaD
Diflunisal—Nausea—Triamcinolone—ulcerative colitis	1.89e-05	0.00096	CcSEcCtD
Diflunisal—Nausea—Methylprednisolone—ulcerative colitis	1.88e-05	0.000958	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	1.88e-05	0.00229	CbGpPWpGaD
Diflunisal—Flurbiprofen—ALB—ulcerative colitis	1.87e-05	0.011	CrCbGaD
Diflunisal—Hypersensitivity—Prednisone—ulcerative colitis	1.85e-05	0.000941	CcSEcCtD
Diflunisal—TTR—Signaling Pathways—SEL1L—ulcerative colitis	1.85e-05	0.00225	CbGpPWpGaD
Diflunisal—Vomiting—Betamethasone—ulcerative colitis	1.83e-05	0.000933	CcSEcCtD
Diflunisal—Vomiting—Dexamethasone—ulcerative colitis	1.83e-05	0.000933	CcSEcCtD
Diflunisal—ALB—Folate Metabolism—ICAM1—ulcerative colitis	1.82e-05	0.00222	CbGpPWpGaD
Diflunisal—Rash—Betamethasone—ulcerative colitis	1.82e-05	0.000925	CcSEcCtD
Diflunisal—Rash—Dexamethasone—ulcerative colitis	1.82e-05	0.000925	CcSEcCtD
Diflunisal—Dermatitis—Dexamethasone—ulcerative colitis	1.82e-05	0.000924	CcSEcCtD
Diflunisal—Dermatitis—Betamethasone—ulcerative colitis	1.82e-05	0.000924	CcSEcCtD
Diflunisal—Headache—Dexamethasone—ulcerative colitis	1.81e-05	0.000919	CcSEcCtD
Diflunisal—Headache—Betamethasone—ulcerative colitis	1.81e-05	0.000919	CcSEcCtD
Diflunisal—Asthenia—Prednisone—ulcerative colitis	1.8e-05	0.000917	CcSEcCtD
Diflunisal—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	1.79e-05	0.00218	CbGpPWpGaD
Diflunisal—Pruritus—Prednisone—ulcerative colitis	1.78e-05	0.000904	CcSEcCtD
Diflunisal—Diarrhoea—Prednisone—ulcerative colitis	1.72e-05	0.000874	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	1.71e-05	0.00209	CbGpPWpGaD
Diflunisal—Nausea—Dexamethasone—ulcerative colitis	1.71e-05	0.000871	CcSEcCtD
Diflunisal—Nausea—Betamethasone—ulcerative colitis	1.71e-05	0.000871	CcSEcCtD
Diflunisal—ALB—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	1.71e-05	0.00208	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IFNG—ulcerative colitis	1.7e-05	0.00207	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	1.69e-05	0.00206	CbGpPWpGaD
Diflunisal—TTR—Disease—SLC11A1—ulcerative colitis	1.68e-05	0.00205	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—RELA—ulcerative colitis	1.68e-05	0.00205	CbGpPWpGaD
Diflunisal—Dizziness—Prednisone—ulcerative colitis	1.66e-05	0.000845	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	1.64e-05	0.002	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS1—ulcerative colitis	1.63e-05	0.00198	CbGpPWpGaD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	1.62e-05	0.00198	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—MMP9—ulcerative colitis	1.62e-05	0.00197	CbGpPWpGaD
Diflunisal—Vomiting—Prednisone—ulcerative colitis	1.6e-05	0.000812	CcSEcCtD
Diflunisal—Rash—Prednisone—ulcerative colitis	1.58e-05	0.000806	CcSEcCtD
Diflunisal—Dermatitis—Prednisone—ulcerative colitis	1.58e-05	0.000805	CcSEcCtD
Diflunisal—ALB—Selenium Micronutrient Network—CRP—ulcerative colitis	1.57e-05	0.00192	CbGpPWpGaD
Diflunisal—Headache—Prednisone—ulcerative colitis	1.57e-05	0.0008	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	1.53e-05	0.00186	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCR1—ulcerative colitis	1.52e-05	0.00185	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	1.52e-05	0.00185	CbGpPWpGaD
Diflunisal—TTR—Disease—MAML2—ulcerative colitis	1.51e-05	0.00184	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	1.49e-05	0.00181	CbGpPWpGaD
Diflunisal—Nausea—Prednisone—ulcerative colitis	1.49e-05	0.000759	CcSEcCtD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	1.48e-05	0.0018	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	1.48e-05	0.0018	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CALM3—ulcerative colitis	1.46e-05	0.00178	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	1.45e-05	0.00176	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.43e-05	0.00174	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	1.42e-05	0.00172	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	1.41e-05	0.00172	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	1.41e-05	0.00171	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IFNG—ulcerative colitis	1.39e-05	0.00169	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	1.38e-05	0.00168	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.38e-05	0.00168	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—RELA—ulcerative colitis	1.37e-05	0.00166	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	1.36e-05	0.00166	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	1.36e-05	0.00166	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	1.34e-05	0.00163	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCL20—ulcerative colitis	1.33e-05	0.00162	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—TGFB1—ulcerative colitis	1.33e-05	0.00162	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	1.28e-05	0.00156	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GNA12—ulcerative colitis	1.25e-05	0.00153	CbGpPWpGaD
Diflunisal—TTR—Disease—CALM3—ulcerative colitis	1.25e-05	0.00152	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL1B—ulcerative colitis	1.24e-05	0.0015	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL2—ulcerative colitis	1.23e-05	0.0015	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	1.21e-05	0.00148	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCR2—ulcerative colitis	1.19e-05	0.00145	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	1.19e-05	0.00144	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—NFKB1—ulcerative colitis	1.15e-05	0.0014	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	1.15e-05	0.0014	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	1.15e-05	0.0014	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ABCB1—ulcerative colitis	1.14e-05	0.00139	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.13e-05	0.00138	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCR6—ulcerative colitis	1.12e-05	0.00136	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	1.11e-05	0.00135	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	1.1e-05	0.00134	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	1.1e-05	0.00134	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	1.09e-05	0.00132	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	1.08e-05	0.00131	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ADCY5—ulcerative colitis	1.06e-05	0.00129	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAML2—ulcerative colitis	1.06e-05	0.00129	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	1.06e-05	0.00128	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CHP1—ulcerative colitis	1.03e-05	0.00125	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	1e-05	0.00122	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTGER4—ulcerative colitis	9.84e-06	0.0012	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	9.82e-06	0.0012	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—ALB—ulcerative colitis	9.76e-06	0.00119	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CHP1—ulcerative colitis	9.75e-06	0.00119	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	9.6e-06	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	9.56e-06	0.00116	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	9.16e-06	0.00111	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	9.05e-06	0.0011	CbGpPWpGaD
Diflunisal—TTR—Disease—ADCY5—ulcerative colitis	9.04e-06	0.0011	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GHRL—ulcerative colitis	9.01e-06	0.0011	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—ulcerative colitis	8.97e-06	0.00109	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	8.95e-06	0.00109	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	8.9e-06	0.00108	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—DLD—ulcerative colitis	8.87e-06	0.00108	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	8.81e-06	0.00107	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—GNA12—ulcerative colitis	8.79e-06	0.00107	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CALM3—ulcerative colitis	8.73e-06	0.00106	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ITGAL—ulcerative colitis	8.63e-06	0.00105	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RIPK2—ulcerative colitis	8.6e-06	0.00105	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TGFB1—ulcerative colitis	8.24e-06	0.001	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CHP1—ulcerative colitis	8.16e-06	0.000993	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PPARG—ulcerative colitis	7.93e-06	0.000965	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	7.93e-06	0.000965	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—ulcerative colitis	7.91e-06	0.000962	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	7.85e-06	0.000955	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SEL1L—ulcerative colitis	7.74e-06	0.000942	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.65e-06	0.000931	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ADRB2—ulcerative colitis	7.46e-06	0.000908	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	7.46e-06	0.000908	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	7.39e-06	0.0009	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL6—ulcerative colitis	7.24e-06	0.000881	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	7.16e-06	0.000871	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ALB—ulcerative colitis	7.13e-06	0.000867	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	7.13e-06	0.000867	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	7.11e-06	0.000865	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—DLD—ulcerative colitis	7.05e-06	0.000857	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	6.97e-06	0.000848	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LTF—ulcerative colitis	6.94e-06	0.000845	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CHP1—ulcerative colitis	6.6e-06	0.000804	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ADCY5—ulcerative colitis	6.33e-06	0.000771	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—ulcerative colitis	6.23e-06	0.000759	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.19e-06	0.000753	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	6.14e-06	0.000747	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CALM3—ulcerative colitis	6.12e-06	0.000745	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	6.09e-06	0.000741	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	5.75e-06	0.0007	CbGpPWpGaD
Diflunisal—ALB—Metabolism—DLD—ulcerative colitis	5.7e-06	0.000694	CbGpPWpGaD
Diflunisal—TTR—Disease—JAK2—ulcerative colitis	5.64e-06	0.000686	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	5.62e-06	0.000684	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	5.37e-06	0.000653	CbGpPWpGaD
Diflunisal—TTR—Disease—CD4—ulcerative colitis	5.34e-06	0.00065	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—ulcerative colitis	5.3e-06	0.000646	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	5.07e-06	0.000618	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.96e-06	0.000603	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC11A1—ulcerative colitis	4.95e-06	0.000602	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	4.74e-06	0.000577	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.69e-06	0.000571	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	4.68e-06	0.00057	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAML2—ulcerative colitis	4.45e-06	0.000541	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.22e-06	0.000514	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	4.18e-06	0.000508	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—ulcerative colitis	4.14e-06	0.000504	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.12e-06	0.000501	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JAK2—ulcerative colitis	3.95e-06	0.00048	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MMP1—ulcerative colitis	3.93e-06	0.000478	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CALM3—ulcerative colitis	3.86e-06	0.00047	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.84e-06	0.000468	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—ulcerative colitis	3.84e-06	0.000467	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RELA—ulcerative colitis	3.82e-06	0.000465	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.73e-06	0.000453	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.69e-06	0.000449	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CALM3—ulcerative colitis	3.66e-06	0.000446	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	3.65e-06	0.000445	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL8—ulcerative colitis	3.6e-06	0.000438	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—ulcerative colitis	3.44e-06	0.000419	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTGS1—ulcerative colitis	3.41e-06	0.000415	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.35e-06	0.000408	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—ulcerative colitis	3.26e-06	0.000397	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NFKB1—ulcerative colitis	3.22e-06	0.000392	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CALM3—ulcerative colitis	3.07e-06	0.000373	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.01e-06	0.000367	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ABCB1—ulcerative colitis	3e-06	0.000366	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—ulcerative colitis	2.9e-06	0.000353	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—ulcerative colitis	2.89e-06	0.000352	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ADCY5—ulcerative colitis	2.8e-06	0.000341	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—JAK2—ulcerative colitis	2.77e-06	0.000337	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS1—ulcerative colitis	2.76e-06	0.000335	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—ulcerative colitis	2.69e-06	0.000327	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ADCY5—ulcerative colitis	2.66e-06	0.000323	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CALM3—ulcerative colitis	2.48e-06	0.000302	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—ulcerative colitis	2.41e-06	0.000294	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ABCB1—ulcerative colitis	2.38e-06	0.00029	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.37e-06	0.000289	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ADCY5—ulcerative colitis	2.22e-06	0.000271	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—ulcerative colitis	2.21e-06	0.000269	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPARG—ulcerative colitis	2.09e-06	0.000254	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—ulcerative colitis	2.02e-06	0.000246	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCB1—ulcerative colitis	1.93e-06	0.000235	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—ulcerative colitis	1.88e-06	0.000229	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—ulcerative colitis	1.88e-06	0.000229	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ADCY5—ulcerative colitis	1.8e-06	0.000219	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPARG—ulcerative colitis	1.66e-06	0.000202	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAK2—ulcerative colitis	1.66e-06	0.000202	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—ulcerative colitis	1.64e-06	0.0002	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD4—ulcerative colitis	1.57e-06	0.000191	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—ulcerative colitis	1.55e-06	0.000189	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—ulcerative colitis	1.49e-06	0.000182	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPARG—ulcerative colitis	1.34e-06	0.000163	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—ulcerative colitis	1.22e-06	0.000148	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—ulcerative colitis	1.13e-06	0.000137	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—ulcerative colitis	1.06e-06	0.000129	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—ulcerative colitis	8.49e-07	0.000103	CbGpPWpGaD
